Search
X4 Pharmaceuticals Inc
XFORAdd to Watchlist
4.130USD
+0.045+1.10%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
375.45MMarket Cap
LossP/E TTM
X4 Pharmaceuticals Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
35.11M
1273.21%
EPS(YoY)
-1.87
66.49%
Analyst Rating
STRONG BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of X4 Pharmaceuticals Inc?
According to X4 Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 35.11M, with a year-on-year change of 1273.21.
What are the current assets of X4 Pharmaceuticals Inc?
According to X4 Pharmaceuticals Inc's FY2025 earnings report, its current assets were 261.58M, with a year-on-year change of 133.19.
What are the total assets of X4 Pharmaceuticals Inc?
According to X4 Pharmaceuticals Inc's FY2025 earnings report, its total assets of X4 Pharmaceuticals Inc were 290.46M, with a year-on-year change of 98.34.
What are the total liabilities of X4 Pharmaceuticals Inc?
According to X4 Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of X4 Pharmaceuticals Inc were 104.17M, with a year-on-year change of -16.19.
What is the total equity of X4 Pharmaceuticals Inc?
According to X4 Pharmaceuticals Inc's FY2025 earnings report, its total equity of X4 Pharmaceuticals Inc was 186.29M, with a year-on-year change of 741.08.
What is the net investment of X4 Pharmaceuticals Inc?
According to X4 Pharmaceuticals Inc's FY2025 earnings report, its net investment of X4 Pharmaceuticals Inc was 8.15M, with a year-on-year change of -87.83.
What is the net financing of X4 Pharmaceuticals Inc?
According to X4 Pharmaceuticals Inc's FY2025 earnings report, its net financing of X4 Pharmaceuticals Inc was 238.63M, with a year-on-year change of 1075.85.
What is the Earnings Per Share (EPS) of X4 Pharmaceuticals Inc?
According to X4 Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.87, with a year-on-year change of 66.49.
What is the net margin of X4 Pharmaceuticals Inc?
According to X4 Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -225.55, with a year-on-year change of 84.60.
What is the gross margin of X4 Pharmaceuticals Inc?
According to X4 Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 83.60, with a year-on-year change of 21.46.
What is the debt-to-asset ratio of X4 Pharmaceuticals Inc?
According to X4 Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 26.27, with a year-on-year change of -49.00.
What is the Return on Equity (ROE) of X4 Pharmaceuticals Inc?
According to X4 Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -75.99, with a year-on-year change of 25.68.
What is the Return on Assets (ROA) of X4 Pharmaceuticals Inc?
According to X4 Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -36.25, with a year-on-year change of -42.16.
What is the operating profit of X4 Pharmaceuticals Inc?
According to X4 Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -86.88M, with a year-on-year change of 38.56.